GeneDx Holdings Q4 Earnings Report: What Investors Need to Know

+0.42% Post

GeneDx Holdings Corp. Class A

WGS

66.89

+0.42%

0.00% Post

GeneDx Holdings (NASDAQ:WGS) released its Q4 earnings on Monday, February 23, 2026 at 06:30 AM.

Here's what's important from the earnings announcement.

Earnings

GeneDx Holdings beat estimated earnings by 16.67%, reporting an EPS of $0.14 versus an estimate of $0.12.

Revenue was up $25.35 million from the same period last year.

Analysis of Past Earnings

The company beat on EPS by $0.12 in the last quarter, resulting in a 4.15% drop share price change the following day.

Here's a look at GeneDx Holdings's past performance:

Quarter	Q3 2025	Q2 2025	Q1 2025	Q4 2024
EPS Estimate	0.37	0.1	0.09	0.1
EPS Actual	0.49	0.5	0.27	0.6
Revenue Estimate	104.32M	85.23M	79.81M	82.24M
Revenue Actual	116.74M	102.69M	87.11M	95.64M

To track all earnings releases for GeneDx Holdings visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.